Europe Cannabis Industry & Marijuana Business News

Canopy’s European cannabis production center expects first sales in September

Sales from Canopy Growth’s large cannabis production center in Denmark are expected to start in September, expanding the limited medical marijuana supply in the German market and giving a boost to the Canadian company’s international revenue. Canopy is among a number of major Canadian cannabis firms using Denmark as a springboard to meet soaring demand for medical […]

Read More

European Parliament calls for uniform definition of medical cannabis

In a move to get more clarity on what medical marijuana is, the European Parliament passed a resolution Wednesday calling on the European Commission and EU countries to provide a legal definition and draw a clear distinction between cannabis-based medicines approved by regulatory bodies, MMJ not supported by clinical trials and other applications of the plant. The patchwork of regulations […]

Read More

Greece challenges Denmark in race to be Europe’s marijuana hub

Greece has received as many as 30 foreign investment applications for medical and industrial cannabis production worth approximately 350 million euros ($400 million), potentially setting up the country to be the European Union’s top supplier of medical cannabis in coming years. While few of the licenses have yet to be approved, that value challenges Denmark’s […]

Read More

Belgium considering medical marijuana agency to govern production, distribution

Belgium’s minority government has proposed a law that calls for the establishment of a medical cannabis agency to oversee production and distribution in pharmacies, hospitals and research institutes. If approved, the law would greatly expand access to medical cannabis in the country, though the most important details – including related regulations – are yet to […]

Read More

Though a ‘positive step,’ WHO recommendations on cannabis fall short for some

The World Health Organization (WHO) made great strides in its recommendations on how cannabis should be scheduled, but the global industry believes there’s more work to be done. Martin Jelsma, drugs and democracy program director, at the Netherlands-based Transnational Institute, emphasized to Marijuana Business Daily that there are “very positive elements in the WHO recommendations,” including: Recognition […]

Read More

In race to win Europe, Aurora Cannabis and other Canadian companies pursue EU-GMP

In an effort to add to their international credibility and gain leverage over competitors, more Canadian medical marijuana firms are aiming to achieve one of the highest levels of quality certification in the world. Only a handful of licensed cultivators in Canada qualify for the EU-Good Manufacturing Practices (EU-GMP) certification, giving them an advantage when […]

Read More

79 applications received for 13 contracts to cultivate medical cannabis in Germany

German officials report high interest in domestic cultivation, with 79 applications submitted for the 13 contracts to be granted. The first application process to select cultivators, which drew 118 applicants despite more stringent minimum requirements, had to be restarted due to legal challenges. The German Federal Institute for Drugs and Medical Devices (BfArM) must now review the applications and […]

Read More

Davos report: Europe could be world’s largest medical marijuana market in 5 years

Europe’s three largest medical cannabis markets could double in size in 2019, making this a “transformative” year for the European market, according to a new report by United Kingdom-based analytics firm Prohibition Partners, launched alongside the Davos World Economic Forum. The European cannabis market’s value skyrocketed last year, with 500 million euros ($560 million) already invested […]

Read More

Cannabis firms in M&A hunt look beyond Canada for growth

Canadian medical cannabis companies are increasingly looking internationally for acquisitions to tap growth while consolidation in the country’s marijuana sector continues to steam ahead. Last year, 140 U.S. cannabis companies were targets of mergers and acquisitions, a substantial increase over 2017’s 86, according to data compiled by Viridian Capital Advisors and shared with Marijuana Business […]

Read More

Aurora targets high-margin cannabis market with CA$175M Whistler acquisition

Alberta’s Aurora Cannabis has agreed to acquire privately held British Columbia-based Whistler Medical Marijuana Corp. – one of Canada’s first licensed producers – for 175 million Canadian dollars ($131 million) in an all-share transaction. The acquisition will add Whistler’s recognized cannabis brand to Aurora’s portfolio. It also provides Aurora a proven export channel. Whistler already […]

Read More